Total Funding
82
29
Total FundingVenture - Series Unknown raised
Growth Score
-8 pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
860528
Octamer Inc. develops pharmaceuticals for AIDS virus and cancer cells to prevent replication. Octamer's rational drug design takes
Jeffrey S. Price: Chairman and Chief Executive Officer- Ernest Kun: Chief Scientific Officer
About the Company
Octamer Inc. develops pharmaceuticals for AIDS virus and cancer cells to prevent replication. Octamer's rational drug design takes advantage of the tremendous growth in understanding of gene expression regulatory systems that has occurred during the past 20 years. Octamer Inc. was founded in 1990 and is based in Tiburon, California.
